WAVE Life Sciences Ltd at JPMorgan Healthcare Conference Transcript
Okay. Good afternoon. I'm Eric Joseph, Senior Biotech Analyst with JPMorgan. And our next presenting company is WAVE Life Sciences. Presenting on behalf of the company is CEO Paul Bolno. There's a Q&A session after the presentation. We'll bring mics around for folks who have questions. And for folks joining via webcast, you can submit questions via the portal. So with that, Paul, thanks for joining us.
Thank you, Eric. And it's great to have an opportunity to present here today and provide an update on the tremendous progress that the team has been making at WAVE. Before we begin, we'll obviously be making some forward-looking statements today, so please refer to our SEC filings.
I think before we start, it's really important, as a reminder to those who are also new to the story of WAVE, to really remind people who we are and what we're doing. WAVE is a clinical-stage RNA medicines company, bringing over a decade of oligonucleotide chemistries innovations
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
